|
CCDC88C expression based on
|
KIRC : Kidney renal clear cell carcinoma
| Comparison | Statistical significance |
| Normal-vs-Primary | 5.619500E-04 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.377100E-04 |
| Normal-vs-Stage2 |
2.700400E-01 |
| Normal-vs-Stage3 |
3.571800E-02 |
| Normal-vs-Stage4 |
1.020490E-02 |
| Stage1-vs-Stage2 |
4.045400E-01 |
| Stage1-vs-Stage3 |
3.528600E-01 |
| Stage1-vs-Stage4 |
9.536600E-01 |
| Stage2-vs-Stage3 |
7.863400E-01 |
| Stage2-vs-Stage4 |
4.286000E-01 |
| Stage3-vs-Stage4 |
4.623600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
1.649510E-04 |
| Normal-vs-AfricanAmerican |
7.342600E-01 |
| Normal-vs-Asian |
6.007000E-01 |
| Caucasian-vs-AfricanAmerican |
1.729640E-01 |
| Caucasian-vs-Asian |
5.389000E-01 |
| AfricanAmerican-vs-Asian |
9.151600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.558510E-04 |
| Normal-vs-Female |
4.836300E-02 |
| Male-vs-Female |
1.011990E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
5.118200E-03 |
| Normal-vs-Age(41-60Yrs) |
1.234110E-02 |
| Normal-vs-Age(61-80Yrs) |
1.480720E-03 |
| Normal-vs-Age(81-100Yrs) |
5.038300E-02 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.341780E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.355600E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
4.918800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
4.755600E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.211200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.321200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
| Subtype descriptions |
| Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
| Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Grade 1 |
1.789170E-01 |
| Normal-vs-Grade 2 |
3.178000E-03 |
| Normal-vs-Grade 3 |
1.031620E-04 |
| Normal-vs-Grade 4 |
1.775380E-01 |
| Grade 1-vs-Grade 2 |
1.089860E-02 |
| Grade 1-vs-Grade 3 |
1.798200E-03 |
| Grade 1-vs-Grade 4 |
6.243500E-02 |
| Grade 2-vs-Grade 3 |
3.346800E-01 |
| Grade 2-vs-Grade 4 |
4.950200E-01 |
| Grade 3-vs-Grade 4 |
2.093400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-ccA subtype |
6.095500E-03 |
| Normal-vs-ccB subtype |
8.20759999999865E-05 |
| ccA subtype-vs-ccB subtype |
4.609600E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
2.974300E-04 |
| Normal-vs-N1 |
6.303900E-03 |
| N0-vs-N1 |
6.252600E-01 |
|
|
